Loading company…
WCC Biomedical develops intradermal drug delivery platforms and microneedle patches.
Founded in 2014 and based in Taiwan, WCC Biomedical develops intradermal drug delivery platforms using its WINMAPTM multilayer microneedle technology. Its products include medical, vaccine and beauty patches for use in healthcare, medicines and vaccines. The company changed its name from Wincoat in 2024 and closed a Series B funding round in June 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in